Literature DB >> 26983938

Trypanosoma cruzi Polyamine Transporter: Its Role on Parasite Growth and Survival Under Stress Conditions.

Chantal Reigada1, Melisa Sayé1, Edward Valera Vera1, Darío Balcazar2, Laura Fraccaroli2, Carolina Carrillo2, Mariana R Miranda1, Claudio A Pereira3.   

Abstract

Trypanosoma cruzi is the etiological agent of Chagas disease, a major health problem in Latin America. Polyamines are polycationic compounds that play a critical role as regulators of cell growth and differentiation. In contrast with other protozoa, T. cruzi is auxotrophic for polyamines because of its inability to synthesize putrescine due to the lack of both, arginine and ornithine decarboxylase; therefore, the intracellular availability of polyamines depends exclusively on transport processes. In this work, the polyamine transporter TcPAT12 was overexpressed in T. cruzi epimastigotes demonstrating that growth rates at different concentrations of polyamines strongly depend on the regulation of the polyamine transport. In addition, parasites overexpressing TcPAT12 showed a highly increased resistance to hydrogen peroxide and the trypanocidal drugs nifurtimox and benznidazole, which act by oxidative stress and interfering the synthesis of polyamine derivatives, respectively. Finally, the presence of putative polyamine transporters was analyzed in T. cruzi, Trypanosoma brucei, and Leishmania major genomes identifying 3-6 genes in these trypanosomatids.

Entities:  

Keywords:  Chagas disease; Polyamine transporter; Trypanosoma cruzi

Mesh:

Substances:

Year:  2016        PMID: 26983938     DOI: 10.1007/s00232-016-9888-z

Source DB:  PubMed          Journal:  J Membr Biol        ISSN: 0022-2631            Impact factor:   1.843


  29 in total

1.  GROWTH AND DIFFERENTIATION IN TRYPANOSOMA CRUZI. I. ORIGIN OF METACYCLIC TRYPANOSOMES IN LIQUID MEDIA.

Authors:  E P CAMARGO
Journal:  Rev Inst Med Trop Sao Paulo       Date:  1964 May-Jun       Impact factor: 1.846

2.  MEGA6: Molecular Evolutionary Genetics Analysis version 6.0.

Authors:  Koichiro Tamura; Glen Stecher; Daniel Peterson; Alan Filipski; Sudhir Kumar
Journal:  Mol Biol Evol       Date:  2013-10-16       Impact factor: 16.240

3.  The amino acid/auxin:proton symport permease family.

Authors:  G B Young; D L Jack; D W Smith; M H Saier
Journal:  Biochim Biophys Acta       Date:  1999-01-08

4.  Functional analysis of the intergenic regions of TcP2beta gene loci allowed the construction of an improved Trypanosoma cruzi expression vector.

Authors:  M P Vazquez; M J Levin
Journal:  Gene       Date:  1999-11-01       Impact factor: 3.688

Review 5.  Chagas disease.

Authors:  Anis Rassi; Anis Rassi; José Antonio Marin-Neto
Journal:  Lancet       Date:  2010-04-17       Impact factor: 79.321

6.  L-arginine uptake and L-phosphoarginine synthesis in Trypanosoma cruzi.

Authors:  C A Pereira; G D Alonso; M C Paveto; M M Flawiá; H N Torres
Journal:  J Eukaryot Microbiol       Date:  1999 Nov-Dec       Impact factor: 3.346

7.  Post genomic analysis of permeases from the amino acid/auxin family in protozoan parasites.

Authors:  León A Bouvier; Ariel M Silber; Camila Galvão Lopes; Gaspar E Canepa; Mariana R Miranda; Renata R Tonelli; Walter Colli; Maria Júlia M Alves; Claudio A Pereira
Journal:  Biochem Biophys Res Commun       Date:  2004-08-27       Impact factor: 3.575

8.  Lack of arginine decarboxylase in Trypanosoma cruzi epimastigotes.

Authors:  Carolina Carrillo; Silvina Cejas; Alejandra Huber; Nélida S González; Israel D Algranati
Journal:  J Eukaryot Microbiol       Date:  2003 Sep-Oct       Impact factor: 3.346

Review 9.  The trypanosomiases.

Authors:  Michael P Barrett; Richard J S Burchmore; August Stich; Julio O Lazzari; Alberto Carlos Frasch; Juan José Cazzulo; Sanjeev Krishna
Journal:  Lancet       Date:  2003-11-01       Impact factor: 79.321

10.  Polyamines in biological samples: rapid and robust quantification by solid-phase extraction online-coupled to liquid chromatography-tandem mass spectrometry.

Authors:  Christoph Magnes; Alexander Fauland; Edgar Gander; Sophie Narath; Maria Ratzer; Tobias Eisenberg; Frank Madeo; Thomas Pieber; Frank Sinner
Journal:  J Chromatogr A       Date:  2014-01-14       Impact factor: 4.759

View more
  6 in total

1.  Genome-wide mutagenesis and multi-drug resistance in American trypanosomes induced by the front-line drug benznidazole.

Authors:  Mônica C Campos; Jody Phelan; Amanda F Francisco; Martin C Taylor; Michael D Lewis; Arnab Pain; Taane G Clark; John M Kelly
Journal:  Sci Rep       Date:  2017-10-31       Impact factor: 4.379

Review 2.  Implication of Apoptosis for the Pathogenesis of Trypanosoma cruzi Infection.

Authors:  Débora Decote-Ricardo; Marise P Nunes; Alexandre Morrot; Celio G Freire-de-Lima
Journal:  Front Immunol       Date:  2017-05-09       Impact factor: 7.561

3.  The superfamily keeps growing: Identification in trypanosomatids of RibJ, the first riboflavin transporter family in protists.

Authors:  Darío E Balcazar; María Cristina Vanrell; Patricia S Romano; Claudio A Pereira; Fernando A Goldbaum; Hernán R Bonomi; Carolina Carrillo
Journal:  PLoS Negl Trop Dis       Date:  2017-04-13

4.  Trypanocidal Effect of Isotretinoin through the Inhibition of Polyamine and Amino Acid Transporters in Trypanosoma cruzi.

Authors:  Chantal Reigada; Edward A Valera-Vera; Melisa Sayé; Andrea E Errasti; Carla C Avila; Mariana R Miranda; Claudio A Pereira
Journal:  PLoS Negl Trop Dis       Date:  2017-03-17

5.  Identification of Trypanosoma cruzi Polyamine Transport Inhibitors by Computational Drug Repurposing.

Authors:  Chantal Reigada; Melisa Sayé; Otto Phanstiel; Edward Valera-Vera; Mariana R Miranda; Claudio A Pereira
Journal:  Front Med (Lausanne)       Date:  2019-11-08

6.  Crystal violet structural analogues identified by in silico drug repositioning present anti-Trypanosoma cruzi activity through inhibition of proline transporter TcAAAP069.

Authors:  Melisa Sayé; Lucrecia Gauna; Edward Valera-Vera; Chantal Reigada; Mariana R Miranda; Claudio A Pereira
Journal:  PLoS Negl Trop Dis       Date:  2020-01-21
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.